ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Angelman
|
|
dm_obrien
|
87 |
44K |
34 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
87
|
44K
|
34
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
dm_obrien
|
168 |
47K |
3 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
168
|
47K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
dm_obrien
|
11K |
5.3M |
3 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
11K
|
5.3M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
dm_obrien
|
11K |
5.3M |
2 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
11K
|
5.3M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Angelmans
|
|
dm_obrien
|
3 |
2.0K |
11 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
3
|
2.0K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
dm_obrien
|
11K |
5.3M |
12 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
11K
|
5.3M
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
dm_obrien
|
1.3K |
690K |
13 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
1.3K
|
690K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
AGM
|
|
dm_obrien
|
10 |
6.3K |
9 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
10
|
6.3K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren CEO to present at BIO & Jefferies conferences in US
|
|
dm_obrien
|
10 |
6.1K |
10 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
10
|
6.1K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
dm_obrien
|
231 |
125K |
6 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
231
|
125K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
dm_obrien
|
231 |
125K |
14 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
231
|
125K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
dm_obrien
|
231 |
125K |
4 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
231
|
125K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
dm_obrien
|
11K |
5.3M |
20 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
11K
|
5.3M
|
20
|
|
ASX - By Stock
|
NEU |
Re:
PH p2 Trial.
|
|
dm_obrien
|
12 |
7.9K |
7 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
12
|
7.9K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
AGM
|
|
dm_obrien
|
10 |
6.3K |
16 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
10
|
6.3K
|
16
|
|
ASX - By Stock
|
JPR |
Re:
Ann: Update on development of L-T gas utilisation infrastructure
|
|
dm_obrien
|
29 |
6.6K |
1 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
29
|
6.6K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
dm_obrien
|
11K |
5.3M |
28 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
11K
|
5.3M
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
dm_obrien
|
194 |
81K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
194
|
81K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
dm_obrien
|
11K |
5.3M |
2 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
11K
|
5.3M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
dm_obrien
|
1.3K |
690K |
8 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
1.3K
|
690K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
dm_obrien
|
131 |
61K |
8 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
131
|
61K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Forecasts 2024
|
|
dm_obrien
|
40 |
20K |
4 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
40
|
20K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Forecasts 2024
|
|
dm_obrien
|
40 |
20K |
23 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
40
|
20K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
dm_obrien
|
11K |
5.3M |
15 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
11K
|
5.3M
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Psychiatric Indications
|
|
dm_obrien
|
16 |
7.7K |
9 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
16
|
7.7K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
dm_obrien
|
210 |
91K |
2 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
210
|
91K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
dm_obrien
|
315 |
160K |
2 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
315
|
160K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
dm_obrien
|
315 |
160K |
26 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
315
|
160K
|
26
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Notification of half-year results & investor web conference
|
|
dm_obrien
|
2 |
2.0K |
40 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
2
|
2.0K
|
40
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
dm_obrien
|
11K |
5.3M |
2 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
11K
|
5.3M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Acadia got Rof Trofenitde AND Global rights for NNZ-2591 for RETT/Fragile X
|
|
dm_obrien
|
44 |
19K |
7 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
44
|
19K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Acadia got Rof Trofenitde AND Global rights for NNZ-2591 for RETT/Fragile X
|
|
dm_obrien
|
44 |
19K |
17 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
44
|
19K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
ROW Rights
|
|
dm_obrien
|
67 |
34K |
3 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
67
|
34K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
ROW Rights
|
|
dm_obrien
|
67 |
34K |
3 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
67
|
34K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
brain trauma extends to the soccer field
|
|
dm_obrien
|
3 |
2.1K |
2 |
23/04/23 |
23/04/23 |
ASX - By Stock
|
3
|
2.1K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
dm_obrien
|
11K |
5.3M |
10 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
11K
|
5.3M
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Hey SPUD
|
|
dm_obrien
|
5 |
1.9K |
9 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
5
|
1.9K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
13 March trading
|
|
dm_obrien
|
120 |
45K |
0 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
120
|
45K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
13 March trading
|
|
dm_obrien
|
120 |
45K |
1 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
120
|
45K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Survey of predictions
|
|
dm_obrien
|
20 |
9.6K |
25 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
20
|
9.6K
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
dm_obrien
|
11K |
5.3M |
19 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
11K
|
5.3M
|
19
|
|
ASX - By Stock
|
AVR |
Re:
The management and the shareholders
|
|
dm_obrien
|
21 |
12K |
7 |
05/05/18 |
05/05/18 |
ASX - By Stock
|
21
|
12K
|
7
|
|
ASX - By Stock
|
CGN |
Re:
Ann: Retraction of ASX announcements
|
|
dm_obrien
|
3 |
1.9K |
0 |
12/04/18 |
12/04/18 |
ASX - By Stock
|
3
|
1.9K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Recommended Reading (from a Saint.)
|
|
dm_obrien
|
26 |
9.3K |
5 |
12/04/18 |
12/04/18 |
ASX - By Stock
|
26
|
9.3K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Recommended Reading (from a Saint.)
|
|
dm_obrien
|
26 |
9.3K |
7 |
12/04/18 |
12/04/18 |
ASX - By Stock
|
26
|
9.3K
|
7
|
|
ASX - By Stock
|
CGN |
Re:
Ann: High Priority Drill Targets Identified from Soil Sampling
|
|
dm_obrien
|
3 |
2.0K |
3 |
26/02/18 |
26/02/18 |
ASX - By Stock
|
3
|
2.0K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Oh how I wish for a trading halt
|
|
dm_obrien
|
17 |
12K |
16 |
26/02/18 |
26/02/18 |
ASX - By Stock
|
17
|
12K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Reasons for consideration
|
|
dm_obrien
|
101 |
64K |
15 |
23/11/17 |
23/11/17 |
ASX - By Stock
|
101
|
64K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
neu
|
|
dm_obrien
|
74 |
47K |
1 |
21/11/17 |
21/11/17 |
ASX - By Stock
|
74
|
47K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
neu
|
|
dm_obrien
|
74 |
47K |
1 |
21/11/17 |
21/11/17 |
ASX - By Stock
|
74
|
47K
|
1
|
|